A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

NCT01185028 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C Infection
HIV Infection

Interventions

DRUG: Nitazoxanide With Pegylated Interferon And Ribavirin

Sponsor

National Institutes of Health Clinical Center (CC)